Literature DB >> 15380156

Myoclonus: current concepts and recent advances.

John N Caviness1, Peter Brown.   

Abstract

Myoclonus presents as a sudden brief jerk caused by involuntary muscle activity. An organisational framework is crucial for determining the medical significance of the myoclonus as well as for its treatment. Clinical presentations of myoclonus are divided into physiological, essential, epileptic, and symptomatic. Most causes of myoclonus are symptomatic and include posthypoxia, toxic-metabolic disorders, reactions to drugs, storage disease, and neurodegenerative disorders. The assessment of myoclonus includes an initial screening for those causes that are common or easily corrected. If needed, further testing may include clinical neurophysiological techniques, enzyme activities, tissue biopsy, and genetic testing. The motor cortex is the most commonly shown myoclonus source, but origins from subcortical areas, brainstem, spinal, and peripheral nervous system also occur. If treatment of the underlying disorder is not possible, treatment of symptoms is worthwhile, although limited by side-effects and a lack of controlled evidence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380156     DOI: 10.1016/S1474-4422(04)00880-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  65 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

Review 2.  Definition and classification of hyperkinetic movements in childhood.

Authors:  Terence D Sanger; Daofen Chen; Darcy L Fehlings; Mark Hallett; Anthony E Lang; Jonathan W Mink; Harvey S Singer; Katharine Alter; Hilla Ben-Pazi; Erin E Butler; Robert Chen; Abigail Collins; Sudarshan Dayanidhi; Hans Forssberg; Eileen Fowler; Donald L Gilbert; Sharon L Gorman; Mark E Gormley; H A Jinnah; Barbara Kornblau; Kristin J Krosschell; Rebecca K Lehman; Colum MacKinnon; C J Malanga; Ronit Mesterman; Margaret Barry Michaels; Toni S Pearson; Jessica Rose; Barry S Russman; Dagmar Sternad; Kathy J Swoboda; Francisco Valero-Cuevas
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 3.  [Myoclonus].

Authors:  H M Meinck
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

4.  Recurrent spinal myoclonus after two episodes of spinal anesthesia at a 1-year interval -A case report-.

Authors:  Jae Jun Lee; Sung Mi Hwang; Jun Sung Lee; Ji Su Jang; So-Young Lim; Sung Jun Hong
Journal:  Korean J Anesthesiol       Date:  2010-12-31

5.  Propriospinal myoclonus with life threatening tonic spasms as paraneoplastic presentation of breast cancer.

Authors:  E Salsano; C Ciano; S Romano; F Cornelio; S Di Donato; D Pareyson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  Myoclonus.

Authors:  Melissa J Nirenberg; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.598

7.  Reticular Myoclonus: It Really Comes From the Brainstem!

Authors:  Martijn Beudel; Jan Willem J Elting; Maarten Uyttenboogaart; Mariska W C van den Broek; Marina A J Tijssen
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

8.  Contrast induced spinal myoclonus after percutaneous coronary intervention.

Authors:  Lauren Abela; Kurt Magri Gatt; James Farrugia; Maria Mallia
Journal:  J Cardiol Cases       Date:  2017-07-21

Review 9.  The clinical approach to movement disorders.

Authors:  Wilson F Abdo; Bart P C van de Warrenburg; David J Burn; Niall P Quinn; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2010-01       Impact factor: 42.937

10.  Central neuraxial anaesthesia presenting with spinal myoclonus in the perioperative period: a case series.

Authors:  Olumuyiwa A Bamgbade; John A Alfa; Wael M Khalaf; Andrew P Zuokumor
Journal:  J Med Case Rep       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.